Cris S Constantinescu - Professor, Division of Clinical Neurology, University of Nottingham, Queen's Medical Centre
Cris S Constantinescu
Dr Constantinescu’s interests include neuroimmunology, multiple sclerosis, experimental models of demyelinating disease, immunologic tolerance, cytokines and neuroimaging. He has authored over 100 peer reviewed articles and is an invited speaker at national and international institutions. He is former recipient of the Physician Scientist Award from the NIH, and Research Grants and Awards from the American Neurological Association. Society affiliations include: Association of British Neurologists, American Academy of Neurology, British Society of Immunology, American Academy of Neurology, European Neuro-Ophthalmology Society (EUNOS), American Association of Immunologists Society for Leukocyte Biology, British Medical Association, American Neurological Association, and International Society of Neuroimmunology.
View Press Release - Prof. Constantinescu becomes European Neurological Review Editor-in-Chiefhere.
Horst Urbach - Professor and Head, Neuroradiology, University Hospital Freiburg
José M Ferro - Full Professor and Director, Neurosciences Department, Santa Maria Hospital, University of Lisbon
José M Ferro
Dr Ferro’s main scientific areas of research are stroke, clinical epidemiology, vascular dementia, vascular cognitive impairment, headache, secondary stroke prevention, clinical decision analysis, cerebral vein thrombosis and subarachnoid haemorrhage.
Dr Ferro has led and leads various research projects, such as the International Study of Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Moreover, he was a member of the Steering Committees of the EAFT, ESPS II, TESS II, TACIP, SCOPE, FOP/ASIA and SAFE II studies, as well as a member of the Scientific Committees of the European Stroke Conference, the 3rd and 4th World Stroke Conference, and the Programme Committee of the Stroke Conference. He was conference chairman of the 10th European Stroke Conference. He is also a member of the EUSI Writing Group.
Dr Ferro was a member of the Scientific Committees of the European Stroke Conference, the 3rd and 4th World Stroke Conference, and the Programme Committee of the Stroke Conference. He was conference chairman of the 10th European Stroke Conference. He is also a member of the EUSI Writing Group.
K Ray Chaudhuri - Professor of Movement Disorders, Neuroscience Research and Development, King's College/University Hospital Lewisham
K Ray Chaudhuri
Author of 150+ peer reviewed publications and book chapters, co-editor of 4 books on Parkinson’s disease and Restless Legs Syndrome.
Prof Chaudhuri serves as chairman of the RLS:UK and International PD non motor group, a member of the Movement Disorders Society appointments committee, the Task force of practice parameter group for PD and RLS, American Academy Neurology, the steering group of the Medicines Management Committee and Gene Therapy Advisory Group for the Department of Health, UK, advisor of the Health Technology Assessment committee of the Department of Health, UK and is the lead clinician for the 18 week pathway for management of PD initiated by the UK, Department of Health.
Nataliya Titova - Senior Researcher at Pirogov Russian National Research Medical University (RNRMU), Moscow and Overseas Honorary Faculty, National Parkinson Foundation Centre of Excellence, King’s College Hospital, London
Dr Nataliya Titova graduated from Pirogov Russian National Research Medical University (Moscow, Russia) and obtained her PhD thesis with research focused on a controlled cross sectional and prospective study on clinical and neurophysiological evaluation of de novo Parkinson's disease patients. She thereafter trained to become a specialist in Movement Disorders and is currently working in the department of neurology, neurosurgery and medical genetics at the Federal State Budgetary Educational Institution of Higher Education «N.I. Pirogov Russian National Research Medical University» of the Ministry of Healthcare of the Russian Federation, Moscow, Russia. She is also an overseas faculty at the National Parkinson Foundation International Parkinson Centre of Excellence at Kings College, London. She as an active teacher and researcher in the field of Parkinson’s disease and related conditions and has a special interest in Parkinson’s non-motor pathophysiology, genetics and biomarker driven assessment of natural history. She is leading an international programme on developing strategies for personalised medicine in PD and has published original research on the topic including a recent viewpoint paper in Movement Disorders. She has also co-edited a landmark Elsevier, 2700-page book addressing the hidden face of non-motor symptoms of Parkinson’s disease. She has recently joined the editorial board of NPJ Parkinson’s Disease (Nature Partnership Journal) as assistant editor and also serves on the editorial board of European Neurological Review. She is also coauthor on several papers on PD pathophysiology and an active member of the Movement Disorders Society PD non motor study group (trainee section) where she is due to become Chair in 2018. More recently she was elected as a member of the Movement Disorders Society Membership and Public Relations committee. She has lectured on non-motor aspects of PD as well as advanced therapies of PD in Russia, Kazakhstan, London, Romania and India, and most recently was faculty at the International Summit on advanced Parkinson’s disease, held in Berlin, 2017.
Peter J Goadsby - Professor of Neurology, Headache Group, King’s College Hospital, London
Peter J Goadsby
Professor Goadsby specialises in the diagnosis and treatment of headache disorders, including migraines and cluster headache and other forms of chronic daily headaches and has authored 400+ peer reviewed publications.
He is an Honorary Consultant Neurologist at the Hospital for Sick Children, Great Ormond St, London, and in the Department of Neurology, University of California, San Francisco. He is currently Chair of the British Association for the Study of Headache.
400+ peer reviewed publications. He is an Honorary Consultant Neurologist at the Hospital for Sick Children, Great Ormond St, London, and in the Department of Neurology, University of California, San Francisco. He is currently Chair of the British Association for the Study of Headache.
European Editorial Board
Aksel Siva - MD, FEAN, Professor of Neurology, Clinical Neuro-immunology Unit and MS Clinic, Department of Neurology, Istanbul University, Cerrahpaşa School of Medicine
Aksel Siva currently works as Professor of Neurology, at the Department of Neurology of Istanbul University, Cerrahpaşa School of Medicine where he was the past-chairman, and continues to head the Clinical Neuro-immunology Unit & Multiple Sclerosis Clinic, and acts as senior advisor of the Headache Clinic.
He served as President of the Turkish Neurological Society (TNS) for three consecutive terms 2003–2009, and is the chair of its scientific committee. He is a founding member of the Turkish Multiple Sclerosis Society and the MS Chapter of the TNS. He has served as an executive committee member of the European Neurological Society (ENS) 2009–2014 and currently is a member of the EAN scientific programme committee (2014–2018). He served on the Education Committee of the World Federation of Neurology (WFN) and currently is the chair of the WFN Standards & Evaluations Committee. He is a member of the European Academy of Neurology, American Academy of Neurology, American Neurological Association and European Headache Federation.
His areas of research interest and work are: clinical neuro-immunology, mainly multiple sclerosis, neuromyelitis optica spectrum disorder (NMOSD), radiologically isolated syndrome (RIS) and neuro-Behçet’s syndrome. He is also involved in clinical work in headaches and neuro-epidemiology. He has authored over 100 peer-reviewed articles and has written many book chapters, and gives lectures as an invited speaker at national and international meetings and institutions.
Angelo Antonini - Professor of Neurology and Director, Parkinson Unit, IRCCS San Camillo, Venice, and University of Padova
Professor Antonini’s research focuses on pharmacology of dopaminergic medications, neuroimaging as well as cognitive and behavioural aspects of Parkinson’s disease. In addition he is actively involved in the use of continuous infusion of levodopa and apomorphine as well as subthalamic nucleus deep brain stimulus (STN-DBS) for the treatment of motor fluctuations and dyskinesia of complicated Parkinson patients.
During his academic career he has published almost 200 peer-reviewed manuscripts and several book chapters. He has many society affiliations, including treasurer of the Association of Parkinsonism and Related Disorders.
Anna Sauerbier - Clinical research fellow, National Parkinson Foundation International Centre of Excellence, King’s College Hospital, London
Dr. Anna Sauerbier is a clinical research fellow at the National Parkinson Foundation International Centre of Excellence, King’s College Hospital, London having received her medical degree from the Justus-Liebig University in Gießen, Germany. Her research interests are the non- motor aspects of movement disorders (clinical and imaging), with a focus on the impact of ethnicity on the expression of non-motor symptoms in Parkinson’s disease. She has published several peer-reviewed papers and book chapters and has presented at international meetings. She is currently working on her PhD project titled: “Range and nature of non- motor symptoms in people with Parkinson's: exploring possible ethnic differences between white Caucasian, black African/Caribbean and South Asian population in London, UK.” at King’s College London. She is the treasurer of the European Association of Young Neurologists and Trainees (EAYNT), the representative of the EAYNT in the liaison committee and an associate member of the International Parkinson and Movement Disorder Society (IPMDS).
Arne Hagen - Past President, Stroke Alliance for Europe (SAFE)
Arne Hagen is past President of Stroke Alliance for Europe. He is also a board member of the European Federation of Neurological Associations and past President of the Norwegian Association for Stroke Survivors. Prior to his stroke in August 1997, he was a Colonel in the Royal Norwegian Air Force. His service in the air force included Aide de Camp for HM King Olav, Commanding Officer at Bardufoss Air Force Station, Chief of the Foreign Liaison Office, Norway and Branch Chief of the NATO headquarters in High Wycombe, UK.
Bengt Winblad - MD, PhD, Professor of Geriatrics and Head of the Division of Neurogeriatrics, Center for Alzheimer Research, Karolinska Institutet
Dawn Langdon - Professor in Neuropsychology, Royal Holloway, University of London
Professor Langdon’s research work centres on psychological aspects of MS and current projects include the efficacy of medication in protecting cognition, cognitive rehabilitation, cognitive profiles in CIS and early MS and cognition in the later stages of MS, including its relation to early disease status.
She is a frequent contributor to international scientific meetings and committees and is a Trustee of the UK MS Trust, with whom she has authored the MS cognition website www.stayingsmart.org.uk.
Elio Scarpini - Professor of Neurology, Department of Neurological Science, ‘Dino Ferrari’ Centre, University of Milan
Professor Scarpini is chief of the Alzheimer Centre of the University of Milan, Ospedale Policlinico. He is particularly interested in clinical and pharmacological aspects of dementias and is involved in many clinical trials with disease-modifying drugs. He is the author of 300+ peer reviewed publications.
Elio Scarpini is a member of the Executive Committee of the European Neurological Society.
Giuliano Avanzini - Professor and Director, Department of Experimental Research and Diagnosis, National Neurological Institute ‘Carlo Besta’
Professor Avanzini’s research is focused on the physiology of the nervous system with emphasis on the major sensory systems, its development and maturation and the cerebral representation of musical activities. He has conducted numerous studies on epilepsy with special reference to genetic factors and the cellular and molecular mechanisms that drive it. He has authored 200+ peer reviewed publications and several books.
Numerous honours including the 2000 Annual Epilepsy Research Award from the American Epilepsy Society and the 2006 European Epileptology Award of the International League against Epilepsy.
Giuliano Avanzini is Past President of the International League Against Epilepsy (ILAE). He has been a member of the executive committee of the ILAE since 1993, where he previously held the positions of Vice-President and Treasurer.
Heinz Reichmann - Professor of Neurology, Chairman, Department of Neurology and Dean of the Medical Faculty, University of Dresden Medical School
Professor Reichmann’s research interests include neuromuscular disorders, extrapyramidal movement disorders and neurosarcoidosis, disorders of energy metabolism in brain and muscle.
He is affiliated with a number of organisations, including President of the European Neurological Society and a member of the following professional associations: the first Chairman of the German Society of Neurology, the second President of the German Parkinson Society, Fellow of the Royal College of Physicians, Subcommittee Chair International Memberships American Academy of Neurology, Chair Scientific Advisory Board UK Parkinson, Member Scientific Advisory Group to the European Medicines Agency, American Neurological Association, American Academy of Neurology, Royal Society of Medicine, European Neurological Society, European Federation of Neurology, New York Academy of Sciences, Movement Disorder Society, Muscular Disorder Society, German Society of Neurology (Advisory Board Member), Association of Neurological Intensive Care.
Ioannis Milonas - Professor and Chairman, Department of Neurology, Thessaloniki Medical School, Aristotle University
Ioannis Milonas is Past President of the European Neurological Society (ENS), as well as member of its executive committee. He is Professor of Neurology at the Medical School of Aristotle University of Thessaloniki and Head of the University Department of Neurology at the AHEPA University Hospital. Moreover, Professor Milonas is a National Representative at the Multiple Sclerosis International Federation (MSIF), a member of the Association of British Neurologists (ABN) and the Royal Society of Medicine (RSM) and serves on the board of directors of the European Committee for Treatment and Research for Multiple Sclerosis. Professor Milonas has written more than 300 papers.
Jacques L De Reuck - Professor of Neurology, Stroke Research Team, University Hospital, Lille
Jacques L De Reuck
Dr De Reuck’s research interests focus on treatment and management of stroke, epilepsy and Parkinson’s disease. He is especially interested in stroke prevention and atrial fibrillation, cerebral blood flow and oxygen metabolism in borderzone and territorial infarcts, CADASIL (Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy), the pathophysiology of carotid artery disease and related clinical syndromes, Parkinsonism in patients with cerebral infarcts, and vagus nerve stimulation for refractory epilepsy.
Dr De Reuck is or has been a principle investigator in the Stroke and Atrial Fibrillation Ensemble (SAFE) II study, and in the Piracetam Acute Stroke Study (PASS). He is the chairman of the Congress Programme Committee of the European Federation of Neurological Societies (EFNS) and a member of the European Task Force on Age-Related White Matter Changes. He has authored 500+ peer reviewed publications.
Dr De Reuck is Past President of the European Federation of Neurological Societies (EFNS)
Joaquim Ferreira - Professor of Neurology and Clinical Pharmacology, Faculty of Medicine, University of Lisbon and Head of CNS - Campus Neurológico, Portugal
Joaquim Ferreira completed his medical degree and PhD in Neurology at the University of Lisbon. He is Professor of Neurology and Clinical Pharmacology at the Faculty of Medicine, University of Lisbon and Head of the Laboratory of Clinical Pharmacology and Therapeutics. He is also the Head of CNS- Campus Neurológico Sénior in Portugal.
He became interested in movement disorders during his medical degree and later undertook a Clinical Pharmacology fellowship with Prof. Olivier Rascol in Toulouse, France.
He is currently the past-chair of the European Section of the International Parkinson and Movement Disorder Society. His major research interests are neuropharmacology, Parkinson’s disease, dystonia and Huntington’s disease.
Jürg Kesselring - Professor and Head, Department of Neurorehabilitation, Rehabilitation Centre, Neuroscience Center Zurich, University of Zurich
Professor Kesselring specialises in rehabilitation of patients with diseases of or trauma to the nervous system, e.g. stroke, brain injury, multiple sclerosis, Parkinson’s disease etc. He has authored 140 Original publications and Editor or Co-Author of 15 books, mainly related to Multiple Sclerosis, Neurorehabilitation, and Magnetic Resonance Imaging.
Since June 2005, Jürg Kesselring has served as President of the Swiss Multiple Sclerosis Society. He is also President of the St. Gallen Foundation for Culture. In December 2010 he was elected a member of the International Committee of the Red Cross (ICRC) co-opted, for which he worked as a physician from 1978 to 1982 as part of several missions.
Leslie J Findley - Professor and Senior Neurologist, Essex Neurosciences Unit, Queen’s Hospital
Leslie J Findley
Professor Findley’s clinical and research interests include general neurology, movement disorders, including Parkinson’s disease and fatigue disorders. He has written more than 100 refereed papers, and more than 100 book chapters or reviews.
From 1993 - 1997 Professor Findley was Chairman of the Parkinson’s disease Society of United Kingdom. Currently he is Chairman, National Tremor Foundation UK, Advisor to the European Parkinson’s Disease Association, Advisor to the International Essential Tremor Association (Chicago, USA) and Trustee to the National ME Centre.
Mary Baker - Past President of the European Brain Council (EBC)
Mary Baker, MBE, the immediate past President of the European Brain Council, immediate past President of the European Federation of Neurological Associations, Consultant to the World Health Organisation (WHO), Member of EFPIA Advisory Board and Chair of the Working Group on Parkinson’s Disease formed by the WHO in May 1997, and a member of the Commission’s CONNECT Advisory Forum. Academic appointments include Associate Membership of the Health Services Research Unit, University of Oxford and Visiting Fellow within the London School of Economics (LSE) Health Centre at the LSE.
An Honorary Doctorate from the University of Surrey was conferred upon Mary in 2003 in recognition of her work within the world of Parkinson’s disease and an honorary Doctor of Science from Aston University awarded in July 2013. In 2009 she received the prestigious British Neuroscience Association Award for Outstanding Contribution to British Neuroscience and for Public Service.
Murat Emre - Professor, Behavioral Neurology and Movement Disorders Unit, Department of Neurology, Istanbul Faculty of Medicine, Istanbul University
Prof. Murat Emre was born in 1956, in Eregli, Turkey. After studying medicine at the Istanbul Faculty of Medicine he was trained in neuroscience and clinical neurology at the University of Zürich. He then worked in the fields of neurorehabilitation and clinical research in Switzerland for several years. He trained in movement disorders with Prof. David Marsden at the Queen Square National Hospital for Nervous Diseases, London and in behavioural neurology with Prof. Marsel Mesulam at the Beth Israel Hospital and Harvard Medical School. In 1996 he was assigned as Professor of Neurology at the İstanbul Faculty of Medicine, Department of Neurology, where he started the Behavioural Neurology and Movement Disorders Unit. His research interests are in Parkinson’s disease and related disorders, in particular cognitive aspects of the disease, Alzheimer’s disease and related dementias. He has authored or co-authored 125 articles and book chapters, and he has been the Editor of several books.
Olivier Godefroy - Professor of Neurology and Chief, Neurology Department, University Hospital of Amiens
Professor Godefroy’s research is focused on the characterisation of the cognitive deficits in relationship with cerebrovascular diseases. He has authored 150+ peer reviewed articles and several books, including The Behavioural and Cognitive Neurology of Stroke. He is a former representative of the Société de Neuropsychologie de Langue Française (SNLF).
Paul Boon - Professor of Neurology and Chairman, Department of Neurology, Ghent University Hospital
Author of 100+ peer reviewed publications.
Professor Boon is a former member of the executive committee of the European Neurological Society (ENS), former member of the scientific programme committee of the American Epilepsy Society (AES), former chair of the Epilepsy Scientists panel of the European Federation of Neurological Societies (EFNS) and past editor-in-chief of Acta Neurologica Belgica, the official journal of the Belgian Neurological Society and of Seizure, the European Journal of Epilepsy.
Between 2005 and 2010, he served as the president of the Belgian League against Epilepsy, founding chapter of the ILAE. Paul Boon was the president of the Belgian Neurological Society (BNS) between 2009 and 2011.
Professor Boon is currently a member of the scientific committee of the European Federation of Neurological Societies (EFNS), a member of the scientific advisory board and chairman of the epilepsy subcommittee of the European Neurological Society (ENS).
Peter Jenner - Professor and Head, Neurodegenerative Diseases Research Group (NDRG), School of Health and Biomedical Sciences, Kings College London
Professor Jenner is Emeritus Professor of Pharmacology at King's College London and has contributed to understanding mechanisms involved in the initiation and progression of nigral cell death in Parkinson's disease.
Professor Jenner has published more than 600 papers. He is a frequent speaker at international congresses and to lay groups of patients and caregivers.
Professor Jenner’s contribution to research has been recognised through the award of Fellowships of the Royal Pharmaceutical Society, The British Pharmacological Society and King’s College London.
Robert M Levy
Professor and Chairman, Department of Neurosurgery and, Co-Director, Shands Jacksonville Neuroscience Institute University of Florida College of Medicine, Florida, US
Dr Levy has authored several neurological surgery texts and published 200+ journal articles, abstracts and national and international presentations. He has been given a number of honours and awards and has been listed in the Best Doctors in America for his work in neurological surgery and radiosurgery.
Robert M Levy MD, PhD - Professor and Chairman, Marcus Neuroscience Institute, Boca Raton Regional Hospital, Boca Raton, Florida, US
Robert M Levy MD, PhD
Dr Levy has authored several neurological surgery texts and published 200+ journal articles, abstracts and national and international presentations. He has been given a number of honours and awards and has been listed in the Best Doctors in America for his work in neurological surgery and radiosurgery.
Roger Bullock - Director, Roger Bullock Consulting/Kingshill Research Centre, Swindon
Stefan Evers - Professor of Neurology and Clinical Neurophysiology, Department of Neurology, University of Münster
Stefan Evers is Head of the Department of Neurology at the Lindenbrunn Hospital in Coppenbrügge, Germany, and Professor of Neurology and Clinical Neurophysiology at the University of Münster, Germany. Professor Evers also holds a PhD in Musicology. He is Honorary Secretary of the International Headache Society and Chair of the Headache Panel of the European Academy of Neurology. His main research interests are headache, pain, epilepsy, stroke and the link between music and medicine. He has authored 320 original publications, undertakes peer reviews and is Editor or Co-Author of eight books.
Susanna Lindvall - Vice President, European Parkinson’s Disease Association (EPDA)
From 1996 to 2002 she was President of the Swedish Parkinson's Disease Association (SPA). Since then she has served on the SPA board and is currently president of the Swedish Parkinson Foundation. Elsewhere, she was a board member of the Arvid Carlson Foundation from 2001 to 2008, and since 2007 she has been a member of the Swedish Parkinson’s Academy steering group. Dr Lindvall has received the Swedish Parkinson’s Disease association Honorary medal.
Werner Poewe - MD, Professor of Neurology and Director of the Department of Neurology at Medical University Innsbruck, Austria
Professor Werner Poewe is Professor of Neurology and Director of the Department of Neurology at Medical University Innsbruck, Austria since 1995.
Professor Poewe’s main research interests in the field of movement disorders are focused on differential and early diagnosis of Parkinson’s disease, its natural history and pharmacological treatment. He has been involved in the steering committees of numerous drug trials in different stages of Parkinson’s disease for the past 20 years and has authored and co-authored more than 650 original articles and reviews in the field of movement disorders.
Professor Poewe served as President of the Austrian Society of Neurology from 2002–2004 as well as as President of the Austrian Parkinson’s Disease Society from 1996–2009. He has been awarded Honorary Membership of the German Society of Neurology as well as the Japanese Society of Neurology and the International Parkinson & Movement Disorder Society. His awards include the Walther-Birkmayer-Prize of the Austrian PD Society, the Dingebauer-Prize of the German Neurological Society as well as the Research Excellence Award of Innsbruck Medical University.
Professor Poewe served as President of the International Movement Disorder Society from 2000–2002. Professor Poewe took over as Chair of the MDS European Section from 2011–2013 and is currently active as member of the Managing Board of the Movement Disorder Scientific Panel of the European Academy of Neurology.
He has served on the Editorial Board of international neurology journals, including Movement Disorders, Journal of Neurology and European Journal of Neurology and is a regular reviewer for major journals, like Lancet Neurology, Brain, Movement Disorders, Neurology and Annals of Neurology.
Said R Beydoun - M.D., FAAN, Professor of Neurology, Keck Medical Center of USC, University of Southern California
Said R Beydoun
Said R. Beydoun, M.D., Professor and Division Chief, Neuromuscular Disorders, at the Department of Neurology at Keck Medicine of USC, University of Southern California. He is Program Director of the ACGME-accredited Clinical Neurophysiology Fellowship, which trains three physicians each year. As a principal investigator, Dr. Beydoun has participated in various research clinical trials. His clinical and research areas of expertise are in the fields of neuropathy, diabetic neuropathies, neuropathic pain and immune-mediated neuromuscular disorders, such as CIDP, multifocal motor neuropathy and myasthenia gravis. He has been published in several scientific journals on topics related to neuromuscular diseases and neuropathies. He is an elected fellow of the American Academy of Neurology and a fellow of the American Association of Neuromuscular and Electrodiagnostic Medicine. He is a member of the advisory board and the scientific committee of the Myasthenia Gravis Foundation of California. He holds board certification by the American Board of Psychiatry and Neurology in Neurology, Clinical Neurophysiology, Pain Medicine, and Neuromuscular Medicine.
View Press Release - Prof. Beydoun becomes US Neurology Editor-in-Chief here.
Donald Schomer, MD - Professor of Neurology, Beth Israel Deaconess Medical Center, and Harvard Medical School
Donald Schomer, MD
Dr Schomer is one of America’s leading experts on epilepsy and has published over 90 peer reviewed articles in this area.
He is affiliated with a number of medical societies, including American Epilepsy Society and the Epilepsy Foundation.
Francois Bethoux, MD - Director, Rehabilitation Services, Mellen Center for Multiple Sclerosis, The Cleveland Clinic
Francois Bethoux, MD
Dr. Bethoux is a principal or co-investigator in a number of research studies in the area of multiple sclerosis rehabilitation, ambulation, and spasticity management. Dr. Bethoux has spoken both nationally and internationally on these topics. Dr. Bethoux's work has been published in many peer-reviewed medical journals. Dr Bethoux also authored several book chapters and co-edited a book on outcome measures for rehabilitation.
Dr. Bethoux has contributed to several expert panels. He currently chairs the Research Interest Group on symptom management of the Consortium of Multiple Sclerosis Centers. He is a member of the American Academy of Neurology and of the International Society for Quality of Life Research.
George Perry, PhD - Dean and Professor, Semmes Distinguished University Chair of Neurobiology, College of Sciences, University of Texas at San Antonio
George Perry, PhD
Professor George Perry is recognized in the field of Alzheimer's disease research particularly for his work on oxidative stress and has authored 1000+ peer-reviewed publications. Numerous Society affiliations, including fellow of the American Association for the Advancement of Sciences, president of the Southwestern and Rocky Mountain Division of American Association for the Advancement of Sciences, Chair of the Board of the National Organization of Portuguese Americans and past-president of the American Association of Neuropathologists. He is an elected member of the Academies of Science of Mexico, Portugal and Spain.
George T Grossberg, MD - Samuel W. Fordyce Professor and Director, Geriatric Psychiatry, Department of Psychiatry & Behavioral Neuroscience, Saint Louis University School of Medicine
George T Grossberg, MD
George T Grossberg completed a medical degree at the St. Louis University School of Medicine in Missouri. His postdoctoral training included an internship at St. John's Mercy Medical Center and a residency in the St. Louis University Department of Psychiatry.
A Diplomat of the National Board of Medical Examiners and a Distinguished Fellow of the American Psychiatric Association, Dr. Grossberg holds membership in several professional societies. Additionally, he started the first Geriatric Psychiatry program in Missouri, as well as the first Alzheimer’s Disease Community Brain Bank. He is a former president of the American Association of Geriatric Psychiatry and Past President of the International Psychogeriatric Association (IPA). He has been a leader in developing mental health programs and in treatment and research in geriatrics. Among his many awards, Dr. Grossberg received the Missouri Adult Day Care Association Outstanding Physician Award for supporting programs that allow seniors to live independently or at home with their families and the Fleishman-Hilliard Award for career contributions to Hilliard geriatrics. He appears regularly on listings of top doctors, including America’s Top Psychiatrists (2008–2016), America’s Top Doctors (2006–2016), Best Doctors in America, and Best Doctors in St. Louis since their inception.
Dr. Grossberg has edited and written 14 books and published over 500+ articles, chapters, and abstracts in the peer-reviewed literature. In 2007 he published The Essential Herb-Drug-Vitamin Interaction Guide: The Safe Way to Use Medications and Supplements Together and in 2017, Psychiatric Consultation In Long-Term Care. He currently serves as medical editor of CNS Senior Care and Section Editor for Geriatric Psychiatry, for Current Geriatric Reports and Current Psychiatry. He is on the editorial boards of Demencia Hoy, International Journal of Alzheimer’s Disease, Journal of Alzheimer’s Disease and Parkinson’s and the Journal of the American Medical Directors Association. He is a consultant in the development of protocols for central nervous system disorders in older patients, and he is involved in a variety of basic as well as clinical research projects in the area of dementing disorders, with a focus on behavioral disturbances in dementia.
Dr. John Bodensteiner was Consultant in Child and Adolescent Neurology at Mayo in Rochester until July 2017.
Dr. John Bodensteiner is the William Pilcher Endowed Chair and Chief of the Pediatric Neurology Division at Barrow.
Dr. Bodensteiner is the current president of the Child Neurology Society and has served in leadership positions in many other capacities during his career in academic pediatric neurology. He has authored or co-authored over 400 scientific publications.
His clinical interests include neuromuscular diseases and genetic syndromes affecting children.
Patrick Y Wen, MD - Neuro-oncologist, and Professor of Neurology, Dana Farber/Brigham and Women’s Cancer Center, Harvard Medical School
Patrick Y Wen, MD
Professor Wen’s research is directed towards the development of new therapies for brain tumors and leptomeningeal metastases using gene therapy, inhibitors of angiogenesis, hormonal therapy and radionuclides. He is also interested in the neurologic complications in cancer patients.
Richard Alan Rison - Clinical Assistant Professor of Neurology, University of Southern California, Keck School of Medicine, Los Angeles County Medical Center
Richard Alan Rison
Richard Alan Rison is a deputy editor of the Journal of Medical Case Reports; an associate neurology editor of BMC Neurology, Grand Rounds, and WebmedCentral; and lead editor for case reports of BMC Research Notes. Dr Rison practices general neurology at Neurology Consultants Medical Group, serves as medical director of the PIH Health Hospital-Whittier Stroke Program and the PIH Health Hospital-Whittier Non-Invasive Vascular Laboratory, is a clinical assistant professor of neurology at the University of Southern California Keck School of Medicine and Los Angeles County Medical Center, and is a fellow of the American Association of Neuromuscular and Electrodiagnostic Medicine. Dr Rison is board-certified by the American Board of Psychiatry and Neurology in neurology and vascular neurology, and neurocritical care and neuroimaging by the United Council of Neurologic Subspecialties. He is also board-certified by the American Board of Electrodiagnostic Medicine in electrodiagnostic medicine. Dr Rison is a former president of the Los Angeles Neurological Society and is a fellow of the American Academy of Neurology and the American Neurological Association.
Dr. Silberstein lectures extensively on the pathogenesis, neurobiology, diagnosis, and treatment of headache. He has published 300+ peer reviewed articles and is the Senior Editor of the 8th edition of Wolff's Headache and Other Head Pain.
He is a Fellow of the American College of Physicians, the American Academy of Neurology, and the American Headache Society. He has served the American Headache Society as President, Treasurer, and Board of Directors member. He has served on the Publications, Scientific, and Education Committees of the American Headache Society and was Co-chairman of the Annual Scientific Meeting. Dr Silberstein is an active member of the American Academy of Neurology and is Co-director of the national and international Headache Guideline Project, in cooperation with the Agency for Health Care Policy and Research. He was the Chairman of the International Headache Society meeting in Philadelphia in 2009. He is Chairman of the headache research group of the World Federation of Neurology.
Awards and honors include: Philadelphia Magazine's Top Docs 2014, 2013,2012,2011,2010.
Stuart Isaacson, MD - Director, Parkinson’s Disease and Movement Disorders Center of Boca Raton Associate Professor of Neurology, FIU Herbert Wertheim College of Medicine
Stuart Isaacson, MD
Dr. Stuart Isaacson directs the Parkinson’s disease and Movement Disorders Center of Boca Raton, a nationally recognized leading clinical research institution that brings community access to phase 2 and phase 3 FDA-regulated clinical research trials testing new treatments for improving the symptoms of Parkinson’s disease and trying to slow its progression. He is the author of 100+ peer reviewed publications.
Carl Sadowsky, M.D. is Director of Research at Premiere Research Institute, the Medical Director of the Memory Disorders Center at Palm Beach Neurology, and is Clinical Professor, Division of Neurology, at Nova Southeastern University in Fort Lauderdale, Florida.
Dr. Sadowsky received his medical degree from Cornell University Medical College. He completed an internship and residency in internal medicine and a residency in neurology, including a chief residency at Dartmouth-Hitchcock Medical Center in Hanover, New Hampshire.
Dr. Sadowsky has participated in numerous clinical trials evaluating the safety and efficacy of various cholinesterase inhibitors in the treatment of Alzheimer’s Disease (AD). He is also a frequent presenter at medical meetings and symposia and a prolific writer. His articles have appeared in such prestigious journals as the Journal of the American Medical Association, Neurology, and Archives of Neurology. His most recent research has focused on comparison of agents used in the treatment of patients with AD, the molecular mechanisms of AD, amyloid imaging in dementia, and ethical issues associated with patient care.
A Fellow of the American Academy of Neurology, Dr. Sadowsky is also on the board of the Southeast Florida Alzheimer’s Association. Among his career distinctions, Dr. Sadowsky is listed in Best Doctors in America and Best Doctors in America, Southeast Region.
Anthony J Furlan, MD - Professor, and Chairman, Department of Neurology, Case Western Reserve University School of Medicine
Anthony J Furlan, MD
Dr. Furlan has published more than 150 research papers in peer-reviewed journals, and multiple books and book chapters.
Dr. Furlan chaired the National Institutes of Health (NIH) Task Force on Hospital Care of Acute Stroke which helped establish hospital guidelines for administration of the clot-dissolving drug tPA. He was co-chair the National Stroke Association Stroke Center Network; founding member of the Brain Attack Coalition; former member of the American Stroke Association Executive Stroke Council, and is a current member of the association's Stroke Center Advisory Committee.
Dr. Furlan is the recipient of the American Heart Association 2000 William M. Feinberg Award for Excellence in Clinical Stroke; the 2004 JCAHO Codman award for improving patient outcomes through systems approaches to stroke care; the 2005 Cleveland Clinic Champion of Quality Award; the 2005 Anthem Impact Business Award; and the 2006 American Heart Association Pacesetter Award for excellence in stroke treatment and research.
Arthur Toga, PhD - Professor of Neurology and Director, Laboratory of Neuro Imaging, University of California, Los Angeles
Arthur Toga, PhD
Professor Toga’s research focuses on neuroimaging, informatics, mapping brain structure and function, and brain atlasing. I developed multimodal imaging and data aggregation strategies and applied them in a variety of neurological diseases and psychiatric disorders. He has authored 500+ peer reviewed articles and several books.
Carlos S Kase, MD - Professor, and Chief of Neurology, Boston University School of Medicine
Carlos S Kase, MD
Dr Kase’s research interests have been in the area of cerebrovascular diseases, performing clinical studies and clinico-pathologic correlations in intracerebral hemorrhage and cerebral infarction. He has authored 100+ peer reviewed publications.
Professor Kase is a member of the American Medical Association, American Academy of Neurology, Stroke Council of the American Heart Association, American Neurological Association, and International Stroke Society. Honorary Member of the Spanish Society of Neurology. Corresponding Member, Chilean Society of Neurology, Neurosurgery, and Psychiatry.
Cheryl Waters has authored numerous articles and book chapters and a book just printed in its sixth edition: Diagnosis and Management of Parkinson's Disease. She has been an investigator in numerous studies involving a variety of new medical and surgical treatments. She is the first to hold the Albert B. and Judith L. Glickman Chair in Neurology.
Dr Hanley’s expertise is in the area of acute brain disorders including: stroke, brain haemorrhage, coma and brain infections. This includes the emergency management, preoperative, postoperative and long-term care of severe brain disorders. He is the author of 200+ peer reviewed articles.
Dr Hanley is a member of the American Academy of Neurology, the American Neurological Association, the American Physiologic Society, and the Society of Critical Care Medicine. He has received the Alexander Humboldt Research Prize for accomplishments in Brain Injury Research.
David A Hafler, MD - Professor of Neurology and Immunobiology, and Chair, Department of Neurology, Yale School of Medicine
David A Hafler, MD
Dr. Hafler is a clinical scientist with a research interest in understanding the mechanism of autoimmunity with a particular interest in inflammatory central nervous system diseases, with over 300 publications in the field of autoimmunity and immunology.
Dr. Hafler has been elected to membership in the American Society of Clinical Investigation, The American Neurological Association, the Alpha Omega Society, and was a Harvey Weaver Scholar of the National Multiple Sclerosis Society.
He received the 1st National Multiple Sclerosis five year Collaborative Center Award for tackling the MS genetic effort.
Fred D Lublin, MD - Saunders Family Professor of Neurology, Mount Sinai School of Medicine
Fred D Lublin, MD
Dr Lublin is an internationally renowned authority on the clinical and scientific aspects of multiple sclerosis and one of the foremost experts in experimental therapies.
Dr Lublin is the author of nineteen chapters, 136 publications and one text, and is a member of a number of medical societies including: the National Multiple Sclerosis Society; the MSSM General Clinical Research Center Advisory Committee; and the Executive Committee of the International Medical & Scientific Board of the Multiple Sclerosis International Federation.
Dr Lublin has been listed in "Who's Who in Frontiers of Science and Technology" and New York Magazine's "Best Doctors" issue every year since 2000.
Professor Richerson’s research is focused on sudden death in epilepsy (SUDEP) and infants (SIDS), GABA mechanisms in epilepsy, non-motor symptoms of Parkinson's disease, control of breathing, sleep, serotonin, and brainstem mechanisms. He is the author of 65 peer reviewed publications.
James C Grotta, MD - Director of Stroke Research, Clinical Innovation and Research Institute, Memorial Hermann Hospital-TMC Director, Mobile Stroke Unit Consortium
James C Grotta, MD
Dr. Grotta's research focuses on development of new therapies for acute stroke patients. He has been funded by the National Institutes of Health (NIH) for laboratory studies on the biology of brain injury and recovery in animal stroke models. He has played a leadership role in many clinical research studies of both thrombolytic drugs and cytoprotective agents after stroke, including an NIH program project to carry out a series of novel pilot studies aimed at amplifying the existing benefits of intravenous TPA (Tissue Plasminogen Activator). Formerly chairman of Neurology at UT Medical School in Houston, and founder of its stroke clinical and training program, in 2014 he launched the nation’s first Mobile Stroke Unit, an ambulance equipped with a CT scanner and on-board expertise to carry out acute stroke diagnosis and treatment on-scene, thereby saving up to an hour of time. He is funded by the American Heart Association and the Patient Centered Research Institute to conduct a comparative effectiveness study of outcomes with Mobile Stroke Unit vs Standard Management.
Dr Grotta has authored more than 350 articles in peer-reviewed journals.
He was a recipient of the Feinberg Award for Excellence in Clinical Stroke (1999), Physician of the Year (2006), and the Eugene Braunwald Academic Mentorship Award (2010), all from the national chapter of the American Heart Association (AHA), and awards for teaching excellence at UT Medical School.
Dr. Cummings is the author of the Neuropsychiatric Inventory (NPI), the most commonly used tool for characterizing behavioural disturbances in dementia syndromes and for measuring the effect of therapies on neuropsychiatric symptoms in Alzheimer's disease and other dementias.
Dr. Cummings is an experienced clinical trialist with expertise in clinical trial design and analysis, global trial implementation, and trial outcome measures. He has published over 600 articles and 35 books on Alzheimer's disease and related topics.
Dr. Cummings' research and leadership in the field of Alzheimer's disease have been recognized with many awards, including the Henderson Award of the American Geriatrics Society, the Research Award of the John Douglas French Alzheimer's Research Foundation, and the Ronald and Nancy Reagan Research Award of the national Alzheimer's Association. In 2010 he was honored by the American Association of Geriatric Psychiatry with their Distinguished Scientist Award.
John J Kelly, MD - Professor and Chairman, Department of Neurology, George Washington University Medical Center
John J Kelly, MD
Dr. Kelly is a well-known authority in neuromuscular disease, especially peripheral neuropathies and EMG manifestations of peripheral nerve disease. He has authored more than 100 articles, chapters and books on these topics.
Laura Marsh, MD - Director, Mental Health Care Line, Michael E DeBakey VA Medical Center.
Professor of Psychiatry and Neurology, Baylor College of Medicine.
Laura Marsh, MD
Dr Marsh has research and clinical expertise in neuropsychiatric disorders and brain imaging research and specific expertise in the psychiatric aspects of Parkinson's disease and epilepsy. She has authored over 100 peer reviewed articles and is a member of the scientific advisory boards for the American Parkinson's Disease Foundation and the National Parkinson’s Foundation. Dr. Marsh is also listed as one of the best doctors in the nation in the field of psychiatry.
Martin R Farlow, MD - Professor of Neurology and Vice-Chairman of Research, Department of Neurology, Indiana University School of Medicine, Indianapolis
Martin R Farlow, MD
Dr Farlow is Professor of Neurology and Vice-Chairman of Research in the Department of Neurology at the Indiana University School of Medicine in Indianapolis. He is also Associate Co-Director of the Indiana Alzheimer’s Disease Center in Indianapolis and leads a large Alzheimer and related dementias clinical trials site in the Department of Neurology and has lead and/or contributed in various ways to over 150 clinical trials over the last 25 years. Dr Farlow received his medical degree from Indiana University School of Medicine and completed an internship in medicine and residency in neurology at the Indiana University Hospitals. Dr Farlow is a member of many professional associations including AAN, ANA and AGS. He is also a founding member in both the American Society of Experimental Neurotherapeutics and the International Society for CNS Clinical Trials and Methodology. Dr Farlow has lectured on the topics of aging, dementia, and Alzheimer’s disease at more than 300 meetings, conferences, and hospitals/medical schools throughout the world. He is a reviewer for numerous scientific journals and on the editorial boards of MedLink and Current Alzheimer Research. A prolific author, Dr Farlow has presented more than 467 abstracts at professional meetings and has authored or co-authored more than 455 articles published in peer-reviewed journals such as Lancet Neurology, Annals of Family Medicine, and Journal of the American Geriatrics Society. Dr Farlow’s research focuses on clinical trials of investigational drugs for the treatment of Alzheimer’s disease and related dementias being the lead investigator for several major studies including; tacrine, donepezil, rivastigmine, CAD106, solanezumab and has interests in trial design and safety. Dr Farlow also has clinically characterized and helped determine genetic linkage for several familial dementias including the second mutation associated with autosomal dominantly inherited Alzheimer’s disease, Gerstmann-Straussler- Scheinker disease and Multi Systems Tauopathy with Dementia.
Michael Schulder, MD - Professor and Vice Chairman , Department of Neurosurgery; Director, Brain Tumor Center, Hofstra Northwell School of Medicine, Manhasset, NY
Michael Schulder, MD
Dr. Schulder has been the principal investigator on trials pioneering new methods of image guidance for neurosurgery, including the incorporation of functional MRI as well as intraoperative MRI. He has received substantial foundation and industrial grant support for his research.
Dr. Schulder is past president of the American Society for Stereotactic and Functional Neurosurgery; founding vice-president of the Intraoperative Imaging Society; secretary-treasurer of the World Society for Stereotactic and Functional Neurosurgery; past president of the Section on History of the American Association of Neurological Surgeons; and an elected member of the American Academy of Neurological Surgery and the Society of Neurological Surgeons.
He has authored more than 70 peer-reviewed articles, 31 abstracts, 17 book chapters and over 200 presentations at national and international meetings. He is the editor of the Handbook of Stereotactic and Functional Neurosurgery. He has received the Leonard Tow Award for Humanism in Medicine and has been elected to the Gold Humanism Honors Society. He has been named as one of the top doctors in the New York metropolitan area annually for over a decade.
Professor Goadsby specializes in the diagnosis and treatment of headache disorders, including migraines and cluster headache and other forms of chronic daily headaches and has authored 400+ peer reviewed publications.
He is an Honorary Consultant Neurologist at the Hospital for Sick Children, Great Ormond St, London, and in the Department of Neurology, University of California, San Francisco. He is currently Chair of the British Association for the Study of Headache.
Richard Wurtman, MD - Cecil H Green Distinguished Professor Emeritus, Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, Massachusetts, US
Richard Wurtman, MD
Richard Wurtman is the Cecil H. Green Distinguished Professor Emeritus at the Massachusetts Institute of Technology and a Professor of Neuroscience in MIT’s Department of Brain & Cognitive Sciences, and of Neuropharmacology in the Harvard – MIT Division of Health Sciences & Technology.
Research performed in Wurtman's laboratory has generated about 1,000 research articles and 200 patents.
Dr. Friedlander's numerous awards include the most prestigious awards for trainees in neurosurgery from both the Congress of Neurological Surgeons and the American Academy of Neurological Surgeons. In addition, he has received the Bayer Cerebrovascular Award and the International Charcot Prize for Motor Neuron Diseases.
Dr. Friedlander is the recipient of the 2012 H. Richard Winn, MD Prize from The Society of Neurological Surgeons. He is an elected member of the American Academy of Neurological Surgeons, The Society of Neurological Surgeons, The American Society for Clinical Investigation (one of five neurosurgeons), and the Association of American Physicians (one of two neurosurgeons).
Rosalind Kalb, PhD - Vice President, Professional Resource Center, National Multiple Sclerosis Society
Rosalind Kalb, PhD
Dr. Kalb is the Vice president of the Professional Resource Center at the National Multiple Sclerosis Society in New York City, developing and providing educational materials and consultation services for healthcare professionals.
Dr. Kalb has authored or edited a number of publications about multiple sclerosis. She is the author of Families Affected by Multiple Sclerosis: Disease Impacts and Coping Strategies, a monograph published in 1995 by the National MS Society and of the Society’s Knowledge is Power series for individuals newly diagnosed with MS. She is also the editor of the Society’s booklet series for health professionals entitled Talking with Your MS Patients about Difficult Topics, and serves on the editorial board of Keep S’myelin, the newsletter for children who have a parent with MS. Dr. Kalb has edited two books–Multiple Sclerosis: The Questions You Have, The Answers You Need, published in its third edition in 2004, and Multiple Sclerosis: A Guide for Families.
Ruben I Kuzniecky, MD - Professor and Vice Chairman, Academic Affairs, and Director, Clinical Research Program, Department of Neurology, Hofstra Northwell Health School of Medicine
Ruben I Kuzniecky, MD
Previously Co-Director of the NYU Comprehensive Epilepsy Center and Director of epilepsy research, Prof. Kuzniecky is now Professor and Vice Chairman, Academic Affairs, and Director, Clinical Research Program, Department of Neurology, Hofstra Northwell Health School of Medicine. He has authored over two hundred books, chapters, and journal articles on a number of topics related to epilepsy, and has received epilepsy research grants from the NIH and numerous foundations. His research focuses on brain imaging and malformations of brain development and epilepsy.
Dr. Kuzniecky has been recognized for his efforts in the "Best Doctors in America" multiple times and with many honorary lectures around the world.
Dr Schreiber’s research focuses on the molecular mechanisms underlying selective neuronal degeneration, a major pathological feature of Alzheimer’s, Parkinson’s and other age-related neurodegenerative diseases. He has published over 100 peer reviewed articles.
Affiliated with the following societies: American Neurological Association, American Academy of Neurology, American Society of Neurorehabilitation, Society for Neuroscience and American Association for the Advancement of Science.
Professor Walkley’s current research interests include the causes and consequences of neuroaxonal dystrophy and ectopic dendritogenesis, altered synaptic function underlying intellectual compromise, the involvement of autophagy and the ubiquitin/proteasomal system in disease progression, and the importance of metabolite salvage in lysosomal processing.
Stewart J Tepper
Professor and Director of Research, Center for Headache and Pain, Cleveland Clinic Neurological Institute
Professor Tepper lectures nationally and internationally on all aspects of headache medicine. His interests are in patient care and education, with research in the causes of headaches, their treatments, and in patient outcomes.
Prof. Tepper serves on the Education Committees of the American Headache Society and the International Headache Society, and belongs to multiple societies including the American Academy of Neurology and the National Headache Foundation.
Stewart J Tepper, MD - Professor of Neurology, Geisel School of Medicine at Dartmouth (Dartmouth Medical School), Hanover, NH; Director, Dartmouth Headache Clinic, Department of Neurology, Dartmouth-Hitchcock Medical Center, Lebanon, NH
Stewart J Tepper, MD
Professor Tepper lectures nationally and internationally on all aspects of headache medicine. His interests are in patient care and education, with research in the causes of headaches, their treatments, and in patient outcomes. He has published over 300 peer-reviewed papers on headache topics and eight books.
Prof. Tepper serves on the Board of Directors and Education Committees of the American Headache Society (AHS) and belongs to multiple societies including the American Academy of Neurology. He is Director of the AHS Scottsdale Headache Symposium and Editor-in-Chief of the journal Headache Currents.